J. Frick

Continuous 5-fluorouracil infusion in refractory carcinoma of the breast

R. Ausman, P. Ritch, T. Anderson, 1987, Breast Cancer Research and Treatment.

Successful high-dose intravenous cytarabine treatment of parenchymal brain involvement from malignant lymphoma.

P. Ritch, T. Anderson, R. Hansen, 1986, Archives of internal medicine.

Successful treatment of meningeal leukemia using systemic high-dose cytosine arabinoside.

P. Ritch, T. Anderson, R. Hansen, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Continuous systemic 5‐fluorouracil infusion in advanced colorectal cancer: Results in 91 patients

R. Ausman, P. Ritch, T. Anderson, 1989, Journal of surgical oncology.

MGMT Inhibition Suppresses Survivin Expression in Pancreatic Cancer

K. Srivenugopal, Anand Patel, J. Weese, 2015, Pancreas.

Vaccines and Antibodies for Therapeutic Use in Cancers

M. Diwan, J. C. Gupta, G. P. Talwar, 2016 .

Conjugation to a Carrier Renders a Self Molecule Immunogenic besides Imparting Immuno-Prophylactic Benefit

R. Naz, G. P. Talwar, J. C. Gupta, 2016 .

The tumor lysis syndrome.

M. Baumann, P. Holoye, J. Frick, 1983, JAMA.

Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study.

P. Wiklund, P. Ekman, J. Fitzpatrick, 1997, British journal of urology.

Chemotherapy re-challenge response rate in metastatic colorectal cancer.

T. Dragovich, R. Gerkin, A. Chambers, 2018, Journal of gastrointestinal oncology.

Sir Peter Freyer Memorial Lecture and Surgical Symposium 15th and 16th September, 1995

K. Lillemoe, H. Pitt, P. Mccarthy, 1995 .